About: The efficacy and safety of neoadjuvant chemotherapy +/− letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The efficacy and safety of neoadjuvant chemotherapy +/− letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 16 October 2011

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 2011 (uk) im Oktober 2011 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 16 October 2011 (en) artículu científicu espublizáu n'ochobre de 2011 (ast)
publication date	wds:Q61852571-37EF43A7-1CE8-40BD-B464-BB259C454DAC
publication date	2011-10-16 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q61852571-D642CB50-3A23-44EF-A94F-6BF92DEE5DCA
language of work or name	English
exact match	wds:Q61852571-4FA5E1FC-742E-4856-B00B-4F66FCB143BE
exact match	https://scigraph.springernature.com/pub.10.1007/s10549-011-1814-6
author name string	wds:Q61852571-0A92EF95-B57E-4F2B-A0EC-2ECBD3AC9FA7 wds:Q61852571-1388BADC-E20B-42D4-A5AB-C4A4D9AC7799 wds:Q61852571-27F4231C-0E4D-4B55-A408-FD16BC0BD891 wds:Q61852571-7BCE7D8C-E29E-49AB-8EC2-5D88CBA9C561 wds:Q61852571-9DD10393-A816-42CC-B68E-BF5FD72A97B5 wds:Q61852571-DF838A8C-99D5-417A-9BB0-6E67A02AFD36 wds:Q61852571-E24A6EE0-8732-4661-8DAD-0BDD3AA9448C
author name string	Ahmad Mosalaei Hamid Nasrolahi Mansour Ansari Abdolrasoul Talei Yaghoub Ashouri Niloofar Amadloo Sare Hoseini
rdfs:label	The efficacy and safety of neoadjuvant chemotherapy +/− letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial (en) The efficacy and safety of neoadjuvant chemotherapy +/− letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial (nl)
skos:prefLabel	The efficacy and safety of neoadjuvant chemotherapy +/− letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial (en) The efficacy and safety of neoadjuvant chemotherapy +/− letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial (nl)
name	The efficacy and safety of neoadjuvant chemotherapy +/− letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial (en) The efficacy and safety of neoadjuvant chemotherapy +/− letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial (nl)
author	wds:Q61852571-A5B78871-FB41-4AFA-A6A2-F47C1BADF457 wds:Q61852571-B13A693C-877C-427C-A817-01BF2246C730 wds:Q61852571-B3084235-D769-40FC-803A-E6EC74329FC7 wds:Q61852571-D5912E27-68A1-4FB0-9824-0DCEF498F106
author	Sedigheh Tahmasebi Mohammad Mohammadianpanah Shapour Omidvari Mohammad Amin Mosleh-Shirazi
title	wds:Q61852571-24119034-43CF-42A8-9306-ED49017BE972
title	The efficacy and safety of neoadjuvant chemotherapy +/- letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial (en)
page(s)	wds:Q61852571-ACD661AE-568B-41A0-8476-C986AD73ECCA
page(s)	853-861
instance of	wds:Q61852571-927C8332-20CD-40D3-885E-7DF2A7CF02BE
instance of	scholarly article
main subject	wds:Q61852571-55975D15-050E-44EC-9FDD-1CF44CD9A320 wds:Q61852571-CBC86F92-A97E-49A2-A51C-414322823805
main subject	chemotherapy phase III clinical trial
PubMed ID	wds:Q61852571-A97BDF84-3D25-4D66-8B4B-FE90F3D9131D
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22002564
PubMed ID	22002564
published in	wds:Q61852571-039D9041-1C40-4E78-8618-2AEB41821162
published in	Breast Cancer Research and Treatment
issue	wds:Q61852571-6FF3CAEA-CDBD-427A-A9B5-472FAA2AB6A4
volume	wds:Q61852571-8CDED649-C72E-45E9-90C2-D433FCC33F24
issue	3
volume	132
DOI	wds:Q61852571-4EAA592E-2905-4A84-83A3-01298CBF7B1D
DOI	http://dx.doi.org/10.1007/S10549-011-1814-6
DOI	10.1007/S10549-011-1814-6
Dimensions Publication ID	wds:Q61852571-D804586B-86A9-4F81-9676-A648B02C96C5
Dimensions Publication ID	1028142478
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q61852571
is cites work of	A Canadian national expert consensus on neoadjuvant therapy for breast cancer: linking practice to evidence and beyond Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-analysis. Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (CBCSG-036): A randomized, controlled, multicenter trial Neoadjuvant endocrine therapy: A potential strategy for ER-positive breast cancer The tumour response of postmenopausal hormone receptor-positive breast cancers undergoing different types of neoadjuvant therapy: a meta-analysis Application of Different methods for Reducing Radiation Dose to Breast during MDCT
is cites work of	wds:Q35239617-698662F1-BC1E-49D4-AD28-0DB3F7B59F11 wds:Q92685576-A5D7E587-877B-4380-AA38-426297710C5E wds:Q92501000-74219B25-F926-424E-9EF4-02D31DF7A97A wds:Q89470896-4B0BAB98-B330-4F65-9B03-B18BD55B3C86 wds:Q60048089-3001E2E5-B4CD-44E7-B1FD-AF12B02C4E27 wds:Q38883281-1D4210EE-3579-4C6B-9FF1-DBB8C3219AAF

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software